**REGISTERED CHARITY NUMBER: 0264173** 

## **Report of the Trustees and** 

**Unaudited Financial Statements** 

**For The Year Ended 31 December 2023** 

**for The British Society for Oral and Dental Research** 

TC Bromhead Limited Harscombe House 1 Darklake View Plymouth Devon PL6 7TL 



**The British Society for Oral and Dental Research** 

## **Contents of the Financial Statements For The Year Ended 31 December 2023** 

|||**Page**||
|---|---|---|---|
|**Reference and Administrative Details**||1||
|**Report of the Trustees**|2|to|4|
|**Independent Examiner's Report**||5||
|**Statement of Financial Activities**||6||
|**Balance Sheet**||7||
|**Notes to the Financial Statements**|8|to|14|
|**Detailed Statement of Financial Activities**||15||





**The British Society for Oral and Dental Research** 

**Reference and Administrative Details For The Year Ended 31 December 2023** 

**TRUSTEES** Dr A Alavi (resigned 1.11.24) Dr Z Brookes Professor P Anderson Professor T Watson **PRINCIPAL ADDRESS** Rooms 2:20:5 Bancroft Building Queen Mary University of London Mile End Road London E1 4NS **REGISTERED CHARITY NUMBER** 0264173 **INDEPENDENT EXAMINER** TC Bromhead Limited Harscombe House 1 Darklake View Plymouth Devon PL6 7TL **INVESTMENT MANAGERS** Evelyn Partners 45 Gresham Street London EC2V 7BG **BANKERS** Natwest Bank Plc 10 Southwark Street London SE1 1TJ 

Page 1 



**The British Society for Oral and Dental Research** 

## **Report of the Trustees For The Year Ended 31 December 2023** 

The trustees present their report with the financial statements of the charity for the year ended 31 December 2023. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019). 

## **OBJECTIVES AND ACTIVITIES** 

## **Objectives and aims** 

The objectives and activities of the Society are as follows: 

- To advance research and increase knowledge for the improvement of oral health in the United Kingdom. 

- To support and represent the oral health research community in the UK. 

- To encourage early career researchers, with dental and/or science qualifications, to be involved in oral and dental 

- research 

- To facilitate the dissemination and application of research findings relating to oral health and interactions between oral and systemic health. 

- To foster the development of international research collaboration through the International Association for Dental Research and its Federations. 

- To promote public engagement and inform of key issues in oral and dental research. 

The objectives and activities of the charity are aimed at improving the oral and dental health of the public through the promotion of advanced research in all branches of dental science. The trustees confirm that they have referred to the guidance contained in the Charity Commission's general guidance on public benefit when reviewing the Society's objectives and activities and in planning future activities.Through research, the aim of the society is to disseminate advances in clinical and scientific research in oral health to members of the dental profession and beyond to improve oral health. 

## **ACHIEVEMENT AND PERFORMANCE** 

## **Charitable activities** 

The aim of the Society is to promote oral and dental research throughout the UK. A key objective is to support those in training and to enable them to present their research at the annual meeting and other bespoke events organised by the society. BSODR Annual meetings occur in the UK (every 2 years), or in Europe, PER (Pan European Region) organised by IADR (International Association for Dental Research) . BSODR also provides funding for bursaries for early career researchers and students to attend these meetings. The funding is dependent on the number of applications received. 

## **FINANCIAL REVIEW** 

## **Financial position** 

The Society's work is reliant on income from membership subscriptions, awards, donations and investments. In the year to 31 December 2023, income from member subscriptions was £13,215 as a result of a slight decrease in membership numbers. Donations and legacies have increased in total by £18,647 which is mostly due to event income being received this year from meetings held. During 2023, charitable expenditure increased by £63,482 due to meeting and event costs incurred this year. 

The Society had net outgoings of £7,177 (2022: net outgoings of £40,225). 

The investments held by the Society at 31 December 2023 increased in market value by £29,827 compared to the previous year end. Income from current investments increased to £11,078 from £8,263 in the previous year. 

## **Investment policy and objectives** 

The investments held by the charity are managed by Evelyn Partners and an amount is held on deposit with NatWest bank. The performance of the investments is reviewed regularly by the Management Committee. The investments held by the charity fall within those permitted by the charity's constitution. 

## **Reserves policy** 

The BSODR Management Committee have a policy of maintaining sufficient level of reserves to enable the charity to fulfil its objectives. 

Restricted reserves of £4,593 are for BSODR prizes, bursaries and sponsorships where the amounts are funded by a third party. More details of the prizes held in restricted funds can be found in note 11. 

Restricted prizes reserves of £4,200 are in relation to Colgate and Septodont prizes not yet paid out to winners. Designated reserves brought forward of £2,000 are to be used towards Early Career Research Awards. 

## **Going concern** 

The trustees consider that there are no material uncertainties about the charity's ability to continue as a going concern. 

Page 2 



**The British Society for Oral and Dental Research** 

## **Report of the Trustees For The Year Ended 31 December 2023** 

## **FUTURE PLANS** 

The Society continues to promote and support oral and dental research. The Management Committee have had several discussions on how best to use more of its funds in subsequent years. Amongst other initiatives, the committee is intending to offer two awards specifically aimed at supporting and rewarding early career researchers and is committed to supporting these awards financially. 

- The BSODR Presidents Award for Early career researchers is to continue. It is intended to identify future highflyers. It will be awarded annually, and the recipients are expected to give a presentation at next BSODR scientific meeting and will be reimbursed up to £350 for travel and accommodation expenses. The prize of £1,000 is to be used to help establish pilot or collaborative research studies. 

- Early Career Research (ECR) Travel Bursary is intended to enable ECRs to travel to BSODR ECR events at a cost of £150 per bursary. The BSODR management committee have reviewed the number of applicants and cost, including event venue support held at academic institutes. 

- BSODR is committed to engage with and have a presence at BDSA (British Society of Dental Students) annual conferences to promote undergraduate dental research in UK. 

- BSODR also intends to initiate BSODR Network events to seed collaborations within the UK to promote/seed collaborations between society members within UK. Funding required to organise, travel and administrative costs are reviewed. 

## **STRUCTURE, GOVERNANCE AND MANAGEMENT** 

## **Governing document** 

The Society is a charity regulated by the Charities Commission of the United Kingdom. The Society was registered on 10 July 1972. Its constitution, detailing the objects, membership rules, organisation, management, the annual meeting, Officers and council was adopted on 6 April 1972 and this was amended on 11 September 2008, 10 September 2013 and 10 September 2020. A copy of this can be found on the Society website, BSODR - The British Society for Oral and Dental Research. 

The Governing Body of the Society shall be the Annual Business Meeting (ABM) of members. The decisions made at the ABM will be implemented by the Management Committee. Decisions required due to ad interim contingencies shall be made by the Management Committee and must be reported to the next ABM. The quorum at the ABM shall be 30. Resolutions presented to any ABM shall be decided by simple majority unless otherwise stated. 

Page 3 



**The British Society for Oral and Dental Research** 

**Report of the Trustees For The Year Ended 31 December 2023** 

## **STRUCTURE, GOVERNANCE AND MANAGEMENT Recruitment and appointment of new trustees** 

## **Management Committee** 

The trustees of the charity are part of a larger team known as the BSODR Management Committee. The Management Committee shall normally consist of the President, President-Elect or Immediate-past President, Honorary Secretary, Honorary Assistant Secretary, Honorary Treasurer, Honorary Assistant Treasurer, Honorary Editor, Webmaster, Chair of the Awards Committee and six Councillors. It shall meet at least once a year. 

The Officers of the Society (President, President-Elect or Immediate-past President, Honorary Secretary and Honorary Treasurer) shall act as an executive group in the intervals between formal meetings of the Management Committee. 

## **Election** 

All members of the Management Committee must be full members of the Society. Election of the Committee members, including the President, will be based on a simple majority vote undertaken by full members of the BSODR. 

## **Nominations** 

The Honorary Secretary will circulate a call for nominations for the Officers of the Society and for vacant positions as Councillor not less than 3 months prior to the ABM. Nominations should normally be received by the Honorary Secretary 2 months before the ABM. Ballots will be sent electronically to the membership at least 4 weeks before the ABM. The ballot will close 1 week before the ABM. The results of the ballot will be announced at the ABM. Individuals wishing to stand for such posts must: 

- Be BSODR members of good standing, 

- Be proposed and seconded for the post by 2 other members of good standing, 

- Sign a declaration of their willingness to serve the Society. 

## **Trustee induction and training** 

On appointment, new trustees spend time with existing trustees to ensure they understand their responsibilities and the legal and financial framework of the Society. 

## **President** 

The Presidential term of office will be 5 years, holding the offices of President-Elect for one year, President for 2 years and Immediate-past President for 2 years. 

## **Other Officers** 

Honorary Secretary, Honorary Assistant Secretary, Honorary Treasurer, Honorary Assistant Treasurer, Webmaster, Honorary Editor and Chair of the Awards Committee: The term of office for each shall be 1 year renewable. 

## **Councillors** 

The term of office of a Councillor shall be three years. Members may not serve as Councillors for directly consecutive terms. Two Councillors shall be replaced each year. In the event that a Councillor demits office after less than 3 years of service, their successor shall serve for the remainder of their term of office, plus 3 years in their own right. 

## **Ad interim vacancies** 

Any position becoming vacant between ABMs shall be filled by an appointee of the Management Committee who will serve for the remaining term of that appointment. 

## **Risk management** 

The trustees have considered the major risks to which the charity is exposed and have reviewed those risks and established systems and procedures to manage those risks. 

The trustees consider variability of investment returns to constitute financial risk and recent extreme volatility in world stock markets has demonstrated this risk. The charity have appointed Evelyn Partners now, an investment Management company to manage its investments. 

The trustees consider a main strategic risk to be the extent to which the research BSODR supports and advocates, support for early career researchers and its student awards successfully advance knowledge and practice for the  benefit of improvements in oral health. This risk is actively discussed and shared with the management committee who meet regularly and evaluate update and profile of all research activities supported by the association and discuss future plans. 

Approved by order of the board of trustees on ............................................. and signed on its behalf by: 

........................................................................ Dr Z Brookes - Trustee 

Page 4 



**Independent Examiner's Report to the Trustees of The British Society for Oral and Dental Research** 

I report to the trustees on my examination of the financial statements of The British Society for Oral and Dental Research Ltd for the year ended 31 December 2023. 

## **Responsibilities and basis of report** 

As the trustees of the charity (and also its directors for the purposes of company law) you are responsible for the preparation of the financial statements in accordance with the requirements of the Companies Act 2006 (the 2006 Act). 

Having satisfied myself that the financial statements of the charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the charity's financial statements carried out under section 145 of the Charities Act 2011 (the 2011 Act). In carrying out my examination I  have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act. 

## **Independent examiner's statement** 

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect: 

- accounting records were not kept in respect of the charity as required by section 386 of the 2006 Act; or 

- the financial statements do not accord with those records; or 

- the financial statements do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or 

- the financial statements have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to 

- charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102). 

I have no concerns and have come across no other matters in connection with the examination to which attention  should be drawn in this report in order to enable a proper understanding of the financial statements to be reached. 

James Groves FCA 

TC Bromhead Limited Harscombe House 1 Darklake View Plymouth Devon PL6 7TL 

Date: ............................................. 

Page 5 



## **The British Society for Oral and Dental Research** 

## **Statement of Financial Activities For The Year Ended 31 December 2023** 

|Unrestricted<br>funds<br>Notes<br>£<br>**INCOME AND ENDOWMENTS FROM**<br>Donations and legacies<br>**49,222**<br>Investment income<br>3<br>**11,078**<br>**Total**<br>**60,300**<br>**EXPENDITURE ON**<br>Raising funds<br>4<br>**2,648**<br>**Charitable activities**<br>Charitable Activities<br>**79,354**<br>**Total**<br>**82,002**<br>Net gains/(losses) on investments<br>**22,989**<br>**NET INCOME/(EXPENDITURE)**<br>**1,287**<br>**RECONCILIATION OF FUNDS**<br>Total funds brought forward<br>**529,042**<br>**TOTAL FUNDS CARRIED FORWARD**<br>**530,329**|Restricted<br>funds<br>£<br>**4,000**<br>**-**<br>**4,000**<br>**-**<br>**12,464**<br>**12,464**<br>**-**<br>**(8,464)**<br>**17,257**<br>**8,793**|**31.12.23**<br>31.12.22<br>**Total**<br>Total<br>**funds**<br>funds<br>**£**<br>£<br>**53,222**<br>34,575<br>**11,078**<br>8,263<br>**64,300**<br>42,838<br>**2,648**<br>2,570<br>**91,818**<br>19,667<br>**94,466**<br>22,237<br>**22,989**<br>(60,826)<br>**(7,177)**<br>(40,225)<br>**546,299**<br>586,524<br>**539,122**<br>546,299|
|---|---|---|



The notes form part of these financial statements 

Page 6 



## **The British Society for Oral and Dental Research** 

## **Balance Sheet 31 December 2023** 

|Unrestricted<br>funds<br>Notes<br>£<br>**FIXED ASSETS**<br>Investments<br>8<br>**435,586**<br>**CURRENT ASSETS**<br>Debtors<br>9<br>**18,109**<br>Cash at bank<br>**93,768**<br>**111,877**<br>**CREDITORS**<br>Amounts falling due within one year<br>10<br>**(17,134)**<br>**NET CURRENT ASSETS**<br>**94,743**<br>**TOTAL ASSETS LESS CURRENT LIABILITIES**<br>**530,329**<br>**NET ASSETS**<br>**530,329**<br>**FUNDS**<br>11<br>Unrestricted funds<br>Restricted funds<br>**TOTAL FUNDS**|Restricted<br>funds<br>£<br>**-**<br>**-**<br>**8,793**<br>**8,793**<br>**-**<br>**8,793**<br>**8,793**<br>**8,793**|**31.12.23**<br>**Total**<br>**funds**<br>**£**<br>**435,586**<br>**18,109**<br>**102,561**<br>**120,670**<br>**(17,134)**<br>**103,536**<br>**539,122**<br>**539,122**<br>**530,329**<br>**8,793**<br>**539,122**|31.12.22<br>Total<br>funds<br>£<br>405,759<br>12,709<br>156,265<br>168,974<br>(28,434)<br>140,540<br>546,299<br>546,299<br>529,042<br>17,257<br>546,299|
|---|---|---|---|



The financial statements were approved by the Board of Trustees and authorised for issue on ............................................. and were signed on its behalf by: 

............................................. 

Z Brookes - Trustee 

The notes form part of these financial statements 

Page 7 



**The British Society for Oral and Dental Research** 

## **Notes to the Financial Statements For The Year Ended 31 December 2023** 

## **1. ACCOUNTING POLICIES** 

## **Basis of preparing the financial statements** 

The financial statements of the charity, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Charities Act 2011. The financial statements have been prepared under the historical cost convention, with the exception of investments which are included at market value, as modified by the revaluation of certain assets. 

## **Income** 

All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably. 

The following specific policies are applied to particular categories of income: 

Donations and legacies are received by way of prize monies, donations and gifts and are included in full in the Statement of Financial Activities when receivable. 

Donated services and facilities are included at the value to the charity where this can be quantified. The value of service provided by volunteers has not been included in these financial statements. 

Investment income is included when receivable. 

An annual subscription fee is received from all members of the Society and is recognised when receivable over the term in which the membership relates. 

## **Expenditure** 

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources. 

## **Taxation** 

The charity is exempt from tax on its charitable activities. 

## **Fund accounting** 

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. 

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. 

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements. 

## **Foreign currencies** 

Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result. 

## **Financial instruments** 

Financial assets and financial liabilities are recognised when the charity becomes a party to the contractual provisions of the instrument. All financial assets and liabilities are initially measured at transaction price. The British Society for Oral and Dental Research only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially measured at transaction value and subsequently measured at their settlement value. 

Page 8 

continued... 



**The British Society for Oral and Dental Research** 

## **Notes to the Financial Statements - continued For The Year Ended 31 December 2023** 

## **1. ACCOUNTING POLICIES - continued** 

Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due. Creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due. Investments are measured at fair value. 

## **Realised gains or losses** 

All gains and losses are taken to the Statement of Financial Activities as they arise. Realised gains and losses on investments are calculated as the difference between sales proceeds and their opening carrying value or their purchase value if acquired subsequent to the first day of the financial year. 

Unrealised gains and losses are calculated as the difference between the fair value at the year end and their carrying value. Realised and unrealised investment gains and losses are combined in the Statement of Financial Activities. 

## **Cash and cash equivalents** 

Cash and cash equivalents include cash in hand, deposits held at call with banks and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities. 

## **2. CRITICAL ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY** 

In the application of the charities accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised, if the revision effects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. 

No significant judgements have been made by management in preparing these financial statements. 

## **3. INVESTMENT INCOME** 

## **4.** 

|**INVESTMENT INCOME**|||
|---|---|---|
||**31.12.23**|31.12.22|
||**£**|£|
|Dividends from investments|**7,585**|6,866|
|Interest received|**3,493**|1,397|
||**11,078**|8,263|
|**RAISING FUNDS**|||
|**Raising donations and legacies**|||
||**31.12.23**|31.12.22|
||**£**|£|
|Support costs|**307**|206|



Page 9 

continued... 



**The British Society for Oral and Dental Research** 

## **Notes to the Financial Statements - continued For The Year Ended 31 December 2023** 

## **4. RAISING FUNDS - continued** 

## **Investment management costs** 

## **5.** 

|**Investment management costs**|||
|---|---|---|
||**31.12.23**|31.12.22|
||**£**|£|
|Portfolio management|**2,341**|2,364|
|Aggregate amounts|**2,648**|2,570|
|**INDEPENDENT EXAMINER'S REMUNERATION**|||
||**31.12.23**|31.12.22|
||**£**|£|
|Fees payable to the charity's auditors for the audit of the charity's financial|||
|statements|**1,250**|1,250|
|Other non-audit services|**12,574**|4,270|



## **6. TRUSTEES' REMUNERATION AND BENEFITS** 

There were no trustees' remuneration or other benefits for the year ended 31 December 2023 nor for the year ended 31 December 2022. 

## **Trustees' expenses** 

There were £1,573 of expenses reimbursed to trustees in the year. (2022: nil) 

## **7. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES** 

|Unrestricted<br>funds<br>£<br>**INCOME AND ENDOWMENTS FROM**<br>Donations and legacies<br>16,975<br>Investment income<br>8,263<br>**Total**<br>25,238<br>**EXPENDITURE ON**<br>Raising funds<br>2,570<br>**Charitable activities**<br>Charitable Activities<br>13,867<br>**Total**<br>16,437<br>Net gains/(losses) on investments<br>(60,826)<br>**NET INCOME/(EXPENDITURE)**<br>(52,025)<br>**RECONCILIATION OF FUNDS**<br>Total funds brought forward<br>581,067<br>**TOTAL FUNDS CARRIED FORWARD**<br>529,042|Restricted<br>funds<br>£<br>17,600<br>-<br>17,600<br>-<br>5,800<br>5,800<br>-<br>11,800<br>5,457<br>17,257|Total<br>funds<br>£<br>34,575<br>8,263<br>42,838<br>2,570<br>19,667<br>22,237<br>(60,826)<br>(40,225)<br>586,524<br>546,299|
|---|---|---|



Page 10 

continued... 



## **The British Society for Oral and Dental Research** 

## **Notes to the Financial Statements - continued For The Year Ended 31 December 2023** 

## **8. FIXED ASSET INVESTMENTS** 

|**FIXED ASSET INVESTMENTS**||
|---|---|
||Listed|
||investments|
||£|
|**MARKET VALUE**||
|At 1 January 2023|**405,759**|
|Additions|**99,133**|
|Disposals|**(67,374)**|
|Revaluations|**(1,932)**|
|At 31 December 2023|**435,586**|
|**NET BOOK VALUE**||
|At 31 December 2023|**435,586**|
|At 31 December 2022|405,759|



There were no investment assets outside the UK. 

Fixed asset investments were valued on an open market basis on 31 December 2023 by Evelyn Partners. The historical cost of the investment were £339,263. 

The investments at fair value comprised: 

|Equities<br>Fixed interest securities<br>Cash held within the investment portfolio<br>Market value as at 31 December 2021<br>**9.**<br>**DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**<br>Prepayments and accrued income<br>**10.**<br>**CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**<br>Other creditors<br>**11.**<br>**MOVEMENT IN FUNDS**|**2023**|2022|
|---|---|---|
||**£**|£|
||**380,469**|326,903|
||**44,897**|44,987|
||**10,130**|33,959|
||||
||**435,586**|405,759|
||||
||**31.12.23**<br>**£**<br>**18,109**<br>**31.12.23**<br>**£**<br>**17,134**|31.12.22<br>£<br>12,709<br>31.12.22<br>£<br>28,434|



|**MOVEMENT IN FUNDS**||||
|---|---|---|---|
|||Net||
|||movement|At|
||At 1.1.23|in funds|31.12.23|
||£|£|£|
|**Unrestricted funds**||||
|General fund|**527,042**|**1,287**|**528,329**|
|Designated funds|**2,000**|**-**|**2,000**|
||**529,042**|**1,287**|**530,329**|
|**Restricted funds**||||
|Restricted funds : Prizes|**11,800**|**(7,600)**|**4,200**|
|Restricted funds : Other|**5,457**|**(864)**|**4,593**|
||**17,257**|**(8,464)**|**8,793**|
|**TOTAL FUNDS**|**546,299**|**(7,177)**|**539,122**|



Page 11 

continued... 



**The British Society for Oral and Dental Research** 

## **Notes to the Financial Statements - continued For The Year Ended 31 December 2023** 

## **11. MOVEMENT IN FUNDS - continued** 

Net movement in funds, included in the above are as follows: 

||Incoming|Resources|Gains and|Movement|
|---|---|---|---|---|
||resources|expended|losses|in funds|
||£|£|£|£|
|**Unrestricted funds**|||||
|General fund|**60,300**|**(82,002)**|**22,989**|**1,287**|
|**Restricted funds**|||||
|Restricted funds : Prizes|**2,500**|**(10,100)**|**-**|**(7,600)**|
|Restricted funds : Other|**1,500**|**(2,364)**|**-**|**(864)**|
||**4,000**|**(12,464)**|**-**|**(8,464)**|
|**TOTAL FUNDS**|**64,300**|**(94,466)**|**22,989**|**(7,177)**|



## **Comparatives for movement in funds** 

|||Net||
|---|---|---|---|
|||movement|At|
||At 1.1.22|in funds|31.12.22|
||£|£|£|
|**Unrestricted funds**||||
|General fund|579,067|(52,025)|527,042|
|Designated funds|2,000|-|2,000|
||581,067|(52,025)|529,042|
|**Restricted funds**||||
|Restricted funds : Prizes|-|11,800|11,800|
|Restricted funds : Other|5,457|-|5,457|
||5,457|11,800|17,257|
|**TOTAL FUNDS**|586,524|(40,225)|546,299|



Comparative net movement in funds, included in the above are as follows: 

||Incoming|Resources|Gains and|Movement|
|---|---|---|---|---|
||resources|expended|losses|in funds|
||£|£|£|£|
|**Unrestricted funds**|||||
|General fund|25,238|(16,437)|(60,826)|(52,025)|
|**Restricted funds**|||||
|Restricted funds : Prizes|17,600|(5,800)|-|11,800|
|**TOTAL FUNDS**|42,838|(22,237)|(60,826)|(40,225)|



Page 12 

continued... 



**The British Society for Oral and Dental Research** 

## **Notes to the Financial Statements - continued For The Year Ended 31 December 2023** 

## **11. MOVEMENT IN FUNDS - continued** 

A current year 12 months and prior year 12 months combined position is as follows: 

|||Net||
|---|---|---|---|
|||movement|At|
||At 1.1.22|in funds|31.12.23|
||£|£|£|
|**Unrestricted funds**||||
|General fund|579,067|(50,738)|528,329|
|Designated funds|2,000|-|2,000|
||581,067|(50,738)|530,329|
|**Restricted funds**||||
|Restricted funds : Prizes|-|4,200|4,200|
|Restricted funds : Other|5,457|(864)|4,593|
||5,457|3,336|8,793|
|**TOTAL FUNDS**|586,524|(47,402)|539,122|



A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows: 

||Incoming|Resources|Gains and|Movement|
|---|---|---|---|---|
||resources|expended|losses|in funds|
||£|£|£|£|
|**Unrestricted funds**|||||
|General fund|85,538|(98,439)|(37,837)|(50,738)|
|**Restricted funds**|||||
|Restricted funds : Prizes|20,100|(15,900)|-|4,200|
|Restricted funds : Other|1,500|(2,364)|-|(864)|
||21,600|(18,264)|-|3,336|
|**TOTAL FUNDS**|107,138|(116,703)|(37,837)|(47,402)|



The designated fund is to be used in the Early Career Research Awards. 

The "Prizes" restricted funds are made up of the following prize funds: 

## Septodont Poster Prize 

Septodont offers a cash award of £500 for the best poster presentation made by a young dental researcher and a £2,000 bursary to the prize-winner's department to support research within the department for the next year. 

## BSODR-GSK-MINTIG Prize 

GlaxoSmithKline offer a prize of £1,500 for travel to a conference or centre of excellence in mineralised tissue research to encourage and stimulate research of the highest standard in this area. 

## Senior Colgate Prize 

The Colgate-Palmolive Company provides a cash award of £500 for the best verbal presentation by a young dental researcher and a £5,000 bursary to the prize-winner's department towards expenses for a postgraduate student to spend time in a research centre of excellence in the UK or abroad. £500 has been paid in advance for 2024 deducted from the Junior Colgate Prize unspent. 

## Junior Colgate Prize 

The Colgate-Palmolive Company provides a cash award of £300 for the best verbal presentation by an undergraduate student and a £3,000 bursary to the prize-winner's department to support undergraduate research in the coming year. £3,000 is unspent at the year end from 2021 less £300 paid in advance for 2024. 

The "Other" restricted funds are made up of the following funds: 

## Colgate Research Symposium sponsorship 

Page 13 

continued... 



**The British Society for Oral and Dental Research** 

## **Notes to the Financial Statements - continued For The Year Ended 31 December 2023** 

## **11. MOVEMENT IN FUNDS - continued** 

The Colgate-Palmolive Company provided £6,000 to sponsor a PER research symposium. There is an unspent balance of £1,962 which the provider has stated can be used for future research symposiums. 

GSK - MINTIG and OMIG Symposium sponsorships 2017 

GlaxoSmithKline provided £1,500 in 2016, £4,000 in 2017 and £1,040 in 2019 to sponsor MINTIG and OMIG symposiums held at the annual meetings.GSK have agreed that the unspent balance of £1,131 can be used to support the Early Career Researcher workshops and other activities of this nature that they will propose in the future. There is a further £1,500 unspent at the year end in relation to the prize for 2023. This is to be paid once recipient confirms method of receipt. 

## **12. RELATED PARTY DISCLOSURES** 

There were no related party transactions for the year ended 31 December 2023. 

Page 14 



## **The British Society for Oral and Dental Research** 

|**Detailed Statement of Financial Activities**|||
|---|---|---|
|**For The Year Ended 31 December 2023**|||
||31.12.23|31.12.22|
||£|£|
|**INCOME AND ENDOWMENTS**|||
|**Donations and legacies**|||
|Prizes|**5,750**|17,600|
|IADR subscriptions|**13,215**|16,154|
|Membership fees|**2,281**|821|
|Event income|**31,976**|-|
||**53,222**|34,575|
|**Investment income**|||
|Dividends from investments|**7,585**|6,866|
|Interest received|**3,493**|1,397|
||**11,078**|8,263|
|**Total incoming resources**|**64,300**|42,838|
|**EXPENDITURE**|||
|**Investment management costs**|||
|Portfolio management|**2,341**|2,364|
|**Charitable activities**|||
|Computer running costs|**2,400**|-|
|Prizes|**23,015**|6,703|
|Bursaries/awards|**6,660**|4,801|
|Meeting & event costs|**45,870**|2,959|
||**77,945**|14,463|
|**Support costs**|||
|**Finance**|||
|Bank charges|**49**|41|
|Foreign exchange profit or loss|**307**|(151)|
||**356**|(110)|
|**Governance costs**|||
|Independent examiner's remuneration|**1,250**|1,250|
|Independent examiner's remuneration non-audit|**12,574**|4,270|
||**13,824**|5,520|
|Total resources expended|**94,466**|22,237|
|**Net (expenditure)/income before gains and**|||
|**losses**|**(30,166)**|20,601|
|**Realised recognised gains and losses**|||
|Realised gains/(losses) on financial assets|||
|measured at FVTPL|**1,095**|-|
|Unrealised gains/losses on investments held|**21,894**|(60,826)|
|**Net expenditure**|**(7,177)**|(40,225)|



This page does not form part of the statutory financial statements 

Page 15 



## **Virtual Cabinet Portal Digital Signatures** 

## **Digital Signature Verification** 

You can verify that this is a genuine Virtual Cabinet Document Portal signed document by uploading it to the following secure web page: 

https://www.virtualcabinetportal.com/VerifySignedDocument 

## **Signature Dates and Times** 

All dates and times shown in the signatures below are expressed in Coordinated Universal Time (UTC), which is generally equivalent to GMT. You can find out more about UTC at the following web page: 

http://www.virtualcabinetportal.com/WhatIsUTC 

## **Signature 1** 

Signed by Zoe Brookes using authentication code Uy9tQlFaajU/SHxN at IP address 86.131.116.215, on 2025/03/09 13:41:26 Z. 

Zoe Brookes's e-mail address is: Zoe.brookes@plymouth.ac.uk. 

